Home Calendar Movers Compare
S&P 500 658.94 +0.47% Nasdaq 588.50 +0.60% Dow 30 466.85 +0.38% Apple 258.86 +1.15% Nvidia 177.39 +0.93% Tesla 352.82 -2.15%
After Hours | 27 companies reporting this week
Home / Calendar / LGND

LGND

Ligand Pharmaceuticals Inc - Class B
$203.61
90-day price trend
+2.01% (+$4.02)
Volume 234,907
52W High $227.92
52W Low $93.58
Market Cap $3.77B
← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data
Consensus EPS
$1.65
Whisper EPS
$1.83
10.7% above consensus
Last Quarter
$2.02
Current Streak
2 Beats
Avg Surprise (4Q)
+4.15%

Next Earnings Report

Reports in 36 days
Report Date May 13, 2026
Whisper Spread +10.72%
Consensus Estimate
$1.65
Official analyst average
Whisper Number
$1.83
What traders expect
Bullish Sentiment: The whisper number is 10.7% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q4 2025 Mar 4, 2026
1-Day: -1.28%
5-Day: -0.38%
Q4 2025 Feb 26, 2026
1-Day: +1.09%
5-Day: +4.11%
Q3 2025 Nov 6, 2025
1-Day: -2.76%
5-Day: +0.23%
Q2 2025 Aug 8, 2025
5-Day: +3.96%

Revenue & Financial Performance

Quarter Revenue YoY Growth Gross Margin Op Margin Net Income
Q4'25 $59.7M +39.4% 143.6% 33.6% $44.8M
Q3'25 $115.5M +122.9% 78.5% 47.6% $117.3M
Q2'25 $47.6M +14.7% 93.9% 17.7% $4.8M
Q1'25 $45.3M +46.3% 89.3% -79.9% -$42.5M
Q4'24 $42.8M +52.4% 93.4% -22.5% -$31.1M
Q3'24 $51.8M +57.6% 75.9% 6.1% -$7.2M
Q2'24 $41.5M +57.5% 136.9% -46.0% -$51.9M
Q1'24 $31.0M -29.6% 64.3% 9.7% $86.1M

Historical Earnings

Last 12 quarters
Quarter Date Consensus Whisper Actual EPS Surprise % Result
Q4 2025 Mar 4, 2026 $1.49 $1.59 $2.02 +35.57% Beat
Q4 2025 Feb 26, 2026 $1.50 $1.61 -- -- --
Q3 2025 Nov 6, 2025 $1.93 $2.04 $3.09 +60.10% Beat
Q2 2025 Aug 8, 2025 $1.43 $1.64 $0.24 -83.22% Missed
Q1 2025 May 5, 2025 $0.78 $0.90 $1.33 +70.51% Beat
Q4 2024 Feb 25, 2025 $1.19 $1.37 $1.27 +6.71% Missed
Q3 2024 Nov 7, 2024 $1.35 $1.55 $1.84 +36.30% Beat
Q2 2024 Aug 6, 2024 $1.06 $1.22 $1.40 +32.08% Beat
Q1 2024 May 7, 2024 $0.78 $0.90 $1.20 +53.85% Beat
Q4 2023 Feb 27, 2024 $0.66 $0.76 $1.38 -- Beat
Q3 2023 Nov 8, 2023 $0.61 $0.70 $1.02 +67.21% Beat
Q2 2023 Aug 8, 2023 $0.64 $0.74 $1.42 -- Beat

Company Information

Symbol
LGND
Company
Ligand Pharmaceuticals Inc - Class B
Market Cap
$3.77B
Next Earnings
May 13, 2026
include __DIR__ . '/includes/footer.php'; ?>